Clinical trial

An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

NCT01077570

Study summary

ClinicalTrials.gov

An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record repaglinide Normalized identity: repaglinide View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2010-03-01

PhaseN/A

Conditions

Diabetesverified · MONDO: diabetes mellitus

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

repaglinideDRUG · verified · RxNorm: repaglinide

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01077570 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.